3
Shared Docs
1
Same-Page
3 / 4
Mentions
0:37:24 +0000 Have you heard of this colestrol Jul 24, 2015 @ 3:23 PM 1,169 views The FDA Approves A Potent And Pricey Cholesterol-Lowering Shot Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. • Follow on Forbes (1970). • • • • • • Full Bio • Rece
ainst heart disease — and the approval is a triumph for Regeneron Pharmaceuticals, the Tarrytown, N.Y.-based biotechnology company that invented it. Praluent is likely to be more widely used, and to cost more, than Wall Steet analysts expected. That also means it could be a big cost down the line. "Obvi
low me on Twitter, circle me onGoogle Plus, or subscribe to my Facebook page. Loading... Loading... The Food and Drug Administration has approved Praluent, a new medicine to lower cholesterol in people who have established heart disease, for people whose risk of a heart attack or stroke is not being ad
rtance: — High Have you heard of this colestrol Jul 24, 2015 @ 3:23 PM 1,169 views The FDA Approves A Potent And Pricey Cholesterol-Lowering Shot Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. ® Follow on Forbes (1970) e Full Bio e Recent Posts ° Popular
Page: HOUSE_OVERSIGHT_025888 →had heart attacks or strokes, who are already taking the maximum dose of a statin they can tolerate. Regeneron and its marketing partner Sanofi say Praluent will have a wholesale cost of $40 a day, or $14,600 a year, for either of two doses, 75 milligrams or 150 mgs. It’s likely that insurance companies w
Page: HOUSE_OVERSIGHT_025889 →layem <q wrote: Have you heard of this colestrol Jul 24, 2015 @ 3:23 PM 1,169 views The FDA Approves A Potent And Pricey Cholesterol-Lowering Shot Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. e Follow on Forbes (1970) ° Full Bio ° Recent Posts ° Popular
Page: HOUSE_OVERSIGHT_026362 →had heart attacks or strokes, who are already taking the maximum dose of a statin they can tolerate. Regeneron and its marketing partner Sanofi say Praluent will have a wholesale cost of $40 a day, or $14,600 a year, for either of two doses, 75 milligrams or 150 mgs. It’s likely that insurance companies w
Page: HOUSE_OVERSIGHT_026363 →Entities connected to both Matthew Herper and Praluent
Regeneron
PERSON
Amgen
ORGANIZATION
John Brennan
PERSON
the Cleveland Clinic
ORGANIZATION
Mark Schoenebaum
PERSON
Pfizer
ORGANIZATIONNissen
PERSON
Troy Brennan
PERSONLeonard S. Schleifer
PERSON
Jeffrey Epstein
PERSON
Geoffrey Porges
PERSONSchleifer
PERSON
Olivier Brandicourt
PERSON
CVS Caremark
ORGANIZATIONTarrytown
LOCATION
Sanford C. Bernstein
ORGANIZATION
the Food and Drug Administration
ORGANIZATION
Donald Trump
PERSONSultan Bin Sulayern
PERSONthe Human Genome
ORGANIZATION